NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kincell Bio

Kincell Bio

Private
Gainesville, FloridaHealthcare & Life Scienceshttps://kincellbio.com/

Last Round

VC Round

May 15, 2025

Total Funding Raised

$36M

Company Overview

Kincell Bio is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for immune cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOcell therapy manufacturinggene therapy manufacturingcontract developmentGMP manufacturingchemistry, manufacturing, and controlsCMCprocess developmentanalytical developmentbiotech manufacturingclinical supplybioprocessingcommercial scale productioncell therapy scale-upbiotech outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kincell Bio Comparables

Compare Kincell Bio with similar companies based on industry and business-model similarity.

Kincell Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
eXmoor Pharma
84%
RoslinCT
81%
OrganaBio
80%

Kincell Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 15, 2025
Series AJul 26, 2023

Key People

Founding team and executive leadership

Mark Bamforth

CEO And Board Chair

Executive Team

Bruce Thompson

Chief Technology Officer

Executive Team

Larry Pitcher

Chief Operating Officer

Executive Team

Kincell Bio Investors

Notable investors and investment history

Kincell Bio investors
InvestorRounds
NewSpring CapitalVC Round
Kineticos VenturesSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Expanded operations in Research Triangle Park, North Carolina.

  • Jan 19, 2026

    Bruce Thompson promoted to President and CTO.

Kincell Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kincell Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kincell Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersGainesville, Florida
Employee Range94
Year Founded2023
Last FundingMay 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.